Cancer patients who quit smoking within six months of diagnosis significantly improve their survival chances, according to a new study from The...
Vous n'êtes pas connecté
MONDAY, Sept 16, 2024 -- A decade of patient follow-up finds a combo of two immunotherapy drugs can greatly extend survival for people with advanced melanomas. In 2011, a diagnosis of advanced, metastatic melanoma typically meant death within 6.5...
Cancer patients who quit smoking within six months of diagnosis significantly improve their survival chances, according to a new study from The...
Drugs designed to target HER2-positive breast cancer could also benefit some patients with bile duct cancer, according to results of a patient trial...
A new study from the MD Anderson Cancer Center reveals that quitting smoking within six months of a cancer diagnosis can significantly improve...
Quitting smoking post-cancer diagnosis boosts survival rates across many cancer types, offering patients a better chance at recovery and improved...
Using a gene signature technique to tailor chemotherapy for patients with early triple-negative breast cancer shows promise as a way to improve...
Researchers have developed an imaging technique to help spot which brain cancer patients will benefit from immunotherapy drugs.
Researchers have developed an imaging technique to help spot which brain cancer patients will benefit from immunotherapy drugs.
A new case report was published in Oncoscience (Volume 11) on October 8, 2024, entitled, “Complete and long-lasting response to immunotherapy in...
Researchers from The University of Texas MD Anderson Cancer Centre, USA, demonstrated that anti-PD-L1 immunotherapy in combination with...
Physical activity of any intensity after a diagnosis of dementia is associated with around a 30% lower risk of death, finds research published online...